Investors

Oncopeptides strives to ensure that analysts, investors, shareholders and financial media are provided with correct information to enhance understanding of our operations.

Nasdaq Stockholm

Price

Change

WEBCAST

Invitation to presentation of the Q2 report 2026

Oncopeptides AB published the report for the second quarter 2026, at 08:00 CET on August 27, 2026. Investors, financial analysts, and media are invited to participate in a webcast and a subsequent Q&A session on August 27 at 09:00 CET.

Latest investor news

August 27, 2026

Sofia Heigis interviewed by Redeye about Q2

Sofia Heigis presented at Aktiespararna

Oncopeptalks: Q1 report

Redeye interviews Oncopeptides CEO Sofia Heigis

Launching: Oncopeptalks as a podcast

CEO Sofia Heigis presented at Redeye event Commercialization in Life Science

Sofia Heigis presented and interviewed at Stockholm Corporate Finance Life Science Days

CEO Sofia Heigis presents Oncopeptides at Aktiespararna

August 27, 2026

Oncopeptides publishes Q2 report 2026

August 20, 2026

Invitation to presentation of the Q2 report 2026

August 17, 2026

Oncopeptides receives list price for Pepaxti in Slovenia, marking first expansion milestone in Central and Eastern Europe

Number of shares and votes in Oncopeptides

No upcoming events

Investor Relations Contact

David Augustsson, MSc

Director of IR and Communications

ir@oncopeptides.com

+46 762 29 38 68

More investor information

The share

General Meeting

Financial Reports

Financial Calendar